関連論文を順次掲載しています
Regulatory and Safety Assessment of COVID-19 mRNA-LNP Genetic Vaccines in Japan: Evidence for Revocation of Approval and Market Withdrawal
日本におけるCOVID-19 mRNA-LNP遺伝子ワクチンの規制および安全性評価: 承認取り消しと市場撤回の根拠
上田潤、宜保美紀、菊池貴幸、平井由里子、三代川真梨子、北川亜希子、志摩勇、児玉慎一郎、福島雅典
Efficacy of Vitamin D Replacement Therapy on 28 Cases of Mylagic Encephalomyelitis/Chronic Fatigue Syndrome After COVID-19 Vaccination

COVID-19 ワクチン接種後発症の筋痛性脳脊髄炎・慢性疲労症候群 28 症例に対するビタミン D補充療養指導の効果
ー英語原文はNutritionに掲載ー

Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan
Cite this article as: Gibo M, Kojima S, Fujisawa A, et al. (April 08, 2024) Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan. Cureus 16(4): e57860. doi:10.7759/cureus.57860
日本における COVID-19 パンデミック時の
mRNA 脂質ナノ粒子ワクチン 3 回接種後の
がん年齢調整死亡率の上昇

COVID-19 遺伝子ワクチンによって誘発される
終末分化組織における自己免疫性炎症反応
Review Article
Autoimmune inflammatory reactions triggered
by the COVID-19 genetic vaccines in terminally
differentiated tissues
Panagis Polykretis, Alberto Donzelli, Janci C. Lindsay, David Wiseman,
Anthony M. Kyriakopoulos, Michael Mörz, Paolo Bellavite, Masanori Fukushima,Stephanie Seneff & Peter A. McCullough
Article: 2259123 | Received 22 May 2023, Accepted 10 Sep 2023, Published online: 14 Sep 2023